- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
Apr 22, 2020
Conduent: Disease Surveillance and Outbreak Management System to Fight Coronavirus
Feb 19, 2020
Diabetic Foot Ulcer Market: Exploring Growth, Innovations, and Patient Care by 2030
Nov 27, 2025
Oryon Raises $21M to Propel Parkinson’s Treatment Progress
Mar 24, 2026
NSL Analytical Services Acquired by May River Capital
Jan 15, 2020
Mobile COVID-19 testing set for Leake and Hinds counties
May 20, 2020
QIAGEN Launched QIAstat-Dx for Transplant Diagnostics in Europe
Sep 12, 2019
Follow us on
